Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CaliPharms Inc KGET

Healthcare Industrials Drug Manufacturers - Specialty & Generic
CaliPharms Inc is a developmental stage acquisition company. The Company is focused on acquiring, merging, and joint venturing with legally permitted fully operational marijuana-cannabis businesses. The Company is seeking acquisitions in medical marijuana-cannabis cultivation. The Company focuses on the medical-grade marijuana-cannabis within the State of California. The Company is also... see more

Recent & Breaking News (GREY:KGET)

CaliPharms Debuts New CBD Muscle & Joint Relief Product at Marijuana Business Conference in Las Vegas

GlobeNewswire November 15, 2018

CaliPharms Launching a New CBD Muscle & Joint Relief Roll On Gel

GlobeNewswire November 13, 2018

CaliPharms has Embarked on the Research and Development of its Initial Series of Naturally Derived CBD (Cannabidiol) Products

GlobeNewswire September 19, 2018

Celebrity Fitness Expert & Formulator Joe Pavlik Joins the CaliPharms Advisory Board

GlobeNewswire August 30, 2018

CaliPharms Enters Discussions With THC Beverage Company and CBD Producer

GlobeNewswire August 23, 2018

Beverage Master Distributor and CaliPharms Execute Definitive Purchase Agreement

GlobeNewswire August 21, 2018

CaliPharms And Beverage Master Distributor Sign LOI

GlobeNewswire August 14, 2018

CaliPharms’ Business Model Not Effected by Jeff Sessions’ Federal Government Enforcement Policies

GlobeNewswire January 11, 2018

Bayport International Holdings, Inc. Engages CaliPharms, Inc. To Expand CBD Product Offering For Weedwiser E-Commerce Platform

GlobeNewswire December 26, 2017

CaliPharms Humboldt County Medical Cannabis Facility Reports Full Production

Marketwired July 13, 2017

CaliPharms Leads California Cannabis Industry with 21st Permit Issued by the County of Humboldt

Marketwired June 5, 2017

CaliPharms Enters Acquisition Discussions with California Cannabis Retailers, Inc.

Marketwired April 17, 2017

CaliPharms Expands its Operations with the Acquisition of Pacific Cannabis Growers

Marketwired March 28, 2017

CaliPharms and Pacific Cannabis Growers Execute Acquisition Term Sheet

Marketwired March 16, 2017

High Performance Beverage Sports Drink Enters the Marijuana Cannabis Space With THC and CBD Performance Drinks

Marketwired March 15, 2017

Cannabis Industry Deals Show Aggregation And Development Of Non-Recreational Brands: 'It's A More Synergistic Approach'

Benzinga.com  February 18, 2017

CaliPharms Announces completion of Cannabis Grow Acquisition -- Company supports Trademarking of Cannabis Products

Marketwired February 7, 2017

KGET Receives Signed Acquisition Term Sheet from Northern California Marijuana Farm

Marketwired January 10, 2017

G-Pel International Plans for Growth in 2015

Accesswire December 4, 2014

MoneyTV with Donald Baillargeon, 10/31

PR Newswire October 31, 2014